ARTICLE | Company News
Merrimack cancer news
October 17, 2016 7:00 AM UTC
Merrimack is reducing headcount by 22% to prioritize R&D “on a focused set of systems biology-derived oncology products.” Merrimack said cuts will not affect the commercial team or the commercial laun...